The Sanofi group has been present in Morocco for more than 50 years. Sanofi was able to seize the opportunity to start manufacturing drugs in 1965 when Morocco developed a national pharmaceutical activity. Commitment that resulted in large-scale scientific, human and industrial investments.

Sanofi’s activities in Morocco Morocco concern the registration, production, distribution and marketing of therapeutic solutions centered on the needs of patients in the main therapeutic areas: Diabetes and Cardiovascular, General Medicine Rare Diseases, Vaccines and Consumer Health.

Leader of the Moroccan pharmaceutical market, Sanofi Maroc achieved a turnover of 1.237 billion dirhams in 2019 and employs 250 people. Sanofi Morocco also has a production and export activity to sub-Saharan Africa, particularly for the antimalarial ASAQ.
Investments and export to Africa
Sanofi Morocco has, in partnership with Euraphrama, an industrial site in Casablanca Zenata.

Sanofi has invested 730 million dirhams over the past 10 years to modernize its industrial and logistics capacities in Morocco.

Production site in Casablanca (Zenata) certified by the WHO for the production of the antimalarial ASAQ Winthrop®
ISO 50001 certification (Energy management)
ISO 14001 certification (Environmental management) and Health and Safety
OHSAS 18001 certification (Health and Safety Management)
GMP (Good Manufacturing Practices) and HSE** (Health, Safety, Environment) compliance
33 million units distributed in 2020, of which 26 million produced locally (87% for the Moroccan market and 13% for export)
8.5% of turnover from exports
79% of the pharmaceutical specialties distributed on the Moroccan and export market are manufactured in Morocco.
More than 500 million treatments of ASAQ Winthrop® (Antimalarial) have been produced since 2007 at the Maphar Zenata industrial site.
20 million treatments of ASAQ Winthrop® were produced at the Maphar Zenata industrial site in 2020
ASAQ Winthrop® is exported to more than 30 countries in sub-Saharan Africa
Investment in a state-of-the-art logistics platform Operational since April 2013

20 million euros of investment
12200m² of surface
14100 pallets
1300 references produced
Radio frequency for inventory management
Pick-to-light system
Compliance with BPD (Best Distribution Practices) and HSE (Health Safety Environment)

2001 – 2021: Sanofi a major player in the fight against malaria